Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Northwestern University
Northwestern University
University of Pittsburgh
University of Birmingham
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Goethe University
Shanghai Zhangjiang Biotechnology Limited Company
National Institutes of Health Clinical Center (CC)
German CLL Study Group
Weill Medical College of Cornell University
Northwestern University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Mayo Clinic
Fred Hutchinson Cancer Center
Baylor College of Medicine
University of Ulm
University of Arizona
New York Medical College
German CLL Study Group
Arbeitsgemeinschaft medikamentoese Tumortherapie
University of California, San Francisco
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
University of Arizona
Ohio State University Comprehensive Cancer Center
University of Chicago
German CLL Study Group
German CLL Study Group
Sanofi
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Arizona
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Stanford University
Mayo Clinic
National Cancer Institute (NCI)
Sanofi
Northside Hospital, Inc.
National Cancer Institute (NCI)
Gruppo Italiano Malattie EMatologiche dell'Adulto
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)